Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Eccogene Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases 2023-11-09 15:05
Holmusk Appoints Eze Abosi as Chief Growth Officer 2023-11-09 08:00
WuXi AppTec Named 2023 Global Contract Research, Development and Manufacturing Organization Company of the Year by Frost & Sullivan 2023-11-09 08:00
Porton Advanced Announces a Strategic Partnership with BioMap, with AI Models Facilitating AAV Gene Therapy Development 2023-11-08 22:31
Complete Genomics' DNBSEQ-T20x2RS* Named "Next Generation Sequencing Solution of the Year" by 2023 BioTech Breakthrough Awards Program 2023-11-08 22:00
China Jo-Jo Drugstores Announces Celebration of its 20th Anniversary 2023-11-08 21:30
Nuvilab Earns Top Honors in Korea's AI Startup 100, Transforming Food Industry with AI Food Scanner 3.0 2023-11-08 14:53
WuXi Biologics Receives AAA MSCI ESG Rating 2023-11-08 08:30
Rootique DUO launches on Indiegogo, revolutionizing hair loss treatment with a 15s mess-free process 2023-11-08 00:00
Nuevocor presents pre-clinical data at ESGCT and AHA meetings 2023-11-07 22:00
MAJOR FITNESS opens pre-orders on its less space, more exercises foldable power rack, the Lightning F35 2023-11-07 22:00
Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial 2023-11-07 21:58
Kexing Biopharm Attended CPHI Worldwide 2023 2023-11-07 20:09
Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis Demonstrating Strong Overall Survival Benefit as First-line Treatment in All-comer Patients with Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) 2023-11-07 20:00
First Mover of Global Trade Index Based On Biome Molecule, Kwanyoung Park of AndKwan Natural Science 2023-11-07 15:47
BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate 2023-11-07 14:14
87.5% ORR | Abbisko presented two clinical updates of Pimicotinib at the 2023 CTOS Annual Meeting 2023-11-07 12:31
AIRS Medical inks partnership agreement with FONAR Corporation, leveraging the experience of the pioneering company in MRI... Success cases to be presented at RSNA 2023 2023-11-07 00:00
Lerna Bio unveils its first-in-class solution to combat liver failure 2023-11-06 22:00
First in the U.S! Palliative Care VR Educational Material by Jolly Good and Emergency Medicine Specialists 2023-11-06 21:00
1 53 54 55 56 57 801